CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="120"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "publications.waset.org",cType: 'non-interactive',cRay: '9135213a4c52f8d0',cH: 'VqD4a1UPNmAXLiVEWYaWw9a6CSlpvrIVLXzOQrHDq_Y-1739788517-1.2.1.1-Ug79ELUi.2ny73ZYrRucqZBvzwhoJkWSllGn9J4idOgJrxN0A7RlKETM4PQBop8Z',cUPMDTk: "\/abstracts\/149119\/immunoglobulin-g-glycosylation-profile-in-influenza-and-covid-19-infected-patients?__cf_chl_tk=YsfVI.kEGQZdk85eboWiWnroBCQoUurVcOaMbMOxVGw-1739788517-1.0.1.1-L_vGNpDkZSk0KtkIhAjDXXWmejCctQNBJK4Vyanxx5s",cFPWv: 'b',cITimeS: '1739788517',cTTimeMs: '1000',cMTimeMs: '120000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/abstracts\/149119\/immunoglobulin-g-glycosylation-profile-in-influenza-and-covid-19-infected-patients?__cf_chl_f_tk=YsfVI.kEGQZdk85eboWiWnroBCQoUurVcOaMbMOxVGw-1739788517-1.0.1.1-L_vGNpDkZSk0KtkIhAjDXXWmejCctQNBJK4Vyanxx5s",md: "fL7eAlIPbMMmZqL77ld58kAgBUL_XOEXiTK6eiI.PXg-1739788517-1.2.1.1-F7e96CglCOifSOdHjWYTNoZYEoj5Z6m.4FvMQqyJC6hKCU.RN7R1q8JOVmM3RZFVU5LFAAMvwlWSVwYMs5nxm5yek6K17H6c8fGR8YRHJCIsUUVIE43kmRqTpKYAZsru6f0ozfY2KP2Ou4lc0hq3mWogkNAuqMr6DfS5u3zlOR_.QkbwpGrVqan3yRUs6bezA1a5xWe4a3WpFLBtJshn4Njhg7yfzQyV66d4ASKrxvdx5FzU5q.Qaq2UMcSs0dvT5pCwRoG5fTFFp.tMFzG1ZyMZ1rIg0aAyR9xL3c5khs_0foElG27vNuFGTMpiXPTob4EbHW_Z7FQLKjdh8OtHzqvg9DRSRh1ON6.TTBeTUPNpJkwL4NMX7DttsCnI3b1vgCSFft91Ioi8nyVq.z2pNrlC2RETPVXO7JheARRKrB0HptqdhdH3k0XrNEJT_bhWQDMN7SMciHDEoP5OQmoYEBMZQF5KDErvfC.PYQhN1q0eBKh_E83UDMvFqS_gDFOi110WvmRXiKWfBeFEmCY3OIPxcZ3PjymcYIUH6UiHmV72gKireZlej75zMW7_wiBH9BjNvcIRA0weFoQY0gfLAj5XiXrdnBJ9agi9BqrjXyVBY8n4kM.QQK6CbQ.qcBME0EM1N.yXQUKMlwIL2SEfJ5GKLaKDYJV64DSJJR7YjM1o.jiYXVuWH7kbrjudy1.ecGdUIiXmJabD4ZlfhvnvKykDTsQIB1rgRczh3JqLLZ9ok8pxTIZa98sZw_siXOeEz5e0o5x.JLfAAHVPjpyZLA1EvmJ7vvC02KARaG.kIXV08xAKtTOSEfq8iZiKa0xTP7jhBvMPKTsqjpimO4Fu0y9LHSMfWAAQXk00S6MYIEH6SXXLzBal18i6UYXxCGsP_5GTv7E3HR4_qhNdeBTbRvKohyG2V7UhATfdO.92g3TPMGjOw5xvH_.8pDW_jN_dXUHWjkJUmB.8TgqrJEJ_5BHjPXiu6wPh514tOv.oXbOe4sG.fBqq2eFY9cnJ53sbcp.oFmKGfqE07eBYxBQ9p_MZuSgheLjQDGs_W_fVR4bZrECcCTk6xR0uzutromIZFo78j0kKNTNUNP204BTHp3ipHMKQRpBDHV6ALEmNI7qBP8X2.aqcvjySSGHO5y1YDeHc7oN1oNAkLCfgzeZyyj_JJFCfv38NFK0_IgMLByRiCFJax4mQ_zbg51sgOKc6SAdWli53CFpIR.1KjAed2HvlANs_J5Qu4AumoZKD7N1IbwDajXnjfGXJp1V5MkZqFpC662Bl5yw3kYrewd.4b5vVnk0TRiE0O8zCBCh09VJ.lXSOLdJnXgSmWZrc3IVn8nfsKJJKCe7Zeva0ev5Ejs_TSCCsfnh2oyT_mGrmGMFx0cQB4h.M86Zs84OQUxFQWoZxhG40khMcQfT75YmNVrENeaguH4_B7ZTsWWI3W8R0XO.XE9klzPfSeYf9A6_Pk8RrIRTip7ITVZxFgOi_5SFN8Ni3nl2a84vNF3MCmHomy5WOzjvJ99pjgO0xxtdDgeuAR9.jzr4S2NOU9C3wHzZpAU8KC_zqy3tRSYkEzKxRw.SK6P3cMhvGMERTL2AysKj2JInsy0UQWJV5fmOYS.BK4nE_BNn8de8Vysn_cwNuNeE6xQTrDx.IoJzP5wxfUdrjwEh3qf9uAaoPI43QlIk1ZI4TUje5Yxt.itvisgEX69yj7nA71w_tHwZzFokSmA2naL5c39dH_hIITyeBAi_Yl4ClcQU_R8YmtLIu4g2tFePyIfa5vNA8d.TxnWth6YQuCKP_Tu2YHxkXsll9ZqX2cUblRo.oISUoGaSHjlQyh7X7rT.2VpAKpJ1gCQ5LKuVL18gb3DuRbkQeQfAQjWIAbwkZigVZzMaYlzfu1OlK.pDokzqmhRrl05hw1PdsnIRg6gDgg8rdoO_LnCXofUIkO1jGYs_pTlfN1kZUCFzEyOXGZsVmVr91_BUGgN3urNXllSsKP6OmHM2wrzpzAp2e_B9ySsHcUQS2NW3HSPgc6hZokha6QVHtIAbitdfiadfl2Pvm_d1Nogrj85jesBg4QjjWnoANZlIGsri6YbC8Uz867Rc0RjSgLdTIHJ.ke.SiB781v1bUOnK0npnnng",mdrd: "F0QyOOHkaLknU5uRCt43IQcRtTiv5JTpWAKJtru3njM-1739788517-1.2.1.1-RDIpC4n.ClbpCxb..iYN017ZmzF1OCcoy3VR94OuJ7yVGPeiJxpVUFBFSG8VYHbQhCZ1XZObQGxw5xU56kXJgGJsywMKncwmWZVwiePzJCvRuJEuUonaScmf83ZlgaJm9_KYHSKdYWHp0aN9y.OTqiAgEuZt3NK59u..wBZNC7vQozM7zpJAaBlBOs4SbpGxFA6fEtZqbjMpc9m8CGyLEFMGYSs0RqxkkFu801Tz7ds19izPlBO5hG8xpCOoJHHC2vylHGSFv34soJwzfsFU45h8pyXCwrqHWccE7B36313tEm8dJ3fXZzVwbrpXux2kyaw.bJ4upHaXgONSbbx9XulxhmPvZOGbFWPpFPzLI.qVCSKnxgSZIGmq5HpcFinOjCpi96f93U8_9gRuWRDxAvcK1V_wlbrQvmyEzF419JtuoC_Frw9f0Uc91A0Z3YdKrFSEKigum9EFfZT2iGP40ry4Q1TIbukD04AnAVA7Qe1MuQc6ATrKTxo0RA3.9n7NtyNCgm3fuPdL4EYG4WsGWn54JX8J6lYRBScfG9Q3cQ4EZPZ46yVUL4ftvKIqgxe2D_yb6vWm57f7QxekSQtERXfBbJjLB6E0P5UuJlR7ENFTc_s6t5pXU2bqV0Vua68Lx3lF_kENLj6_Tc385NU2hKJNOQOB8915n2mtm9HtDFt66cTi_MKABLsM04iJRBzNap4QxMekJS4UHTQHzzxI41D9RyAxUydTbZJLDzCx9CpaFw_MHDZdEjhTe2YkhJtkphTs9K_xK8D284AcCj5k35_k7K71vgSpuiujOdraosV_DfOXJUtoP8jqiWJ2P0sS9RcSqcLvAAjkAIVP.YIkuL0C8IR4TSvdG7p.rxXXWzZDLZoD4UgDuZKn.2GEmGvO.7R4d29D016LCcN6Bh4CAGvCANRwl76CbbXMUQNgD4oMRTSrKHvWkmsUrqjaQyT_hWWIiG4rFggigouJ6SVJcuS_uZPouOCD2hArUxXJIJbMTxakd9ozZOlupZDL1jvHpYazaprm68po6P_6E.a5cB6NXNtnJQ8apNCZHQl.t3pjklyPf8kGbYE4XoBNrag7Hxu_0JwYEAXWCMqp72mSg0jsisZJ_0xJ7mhn956WZMG8E8vmQ3E4dFT7Muksl1G2ZkFX_Y7rgEHuWhqRg42HOfU1L_WPPBScK5xip.ipjTKqQ7nzfr3R8XZtew5J7rsCzNfuHNAuaGjQGPaAea6Uj7aZ6abtci1llIcLtMgXdKjS3Ds4oOqP9QG3MBGgJJ51c4fwkv49aFKun4OalOz1jj9o36jUCpH8xXCKGMWSozTj8DcMAwt7BrmETJdoAgDQ.kq7DL5uxST1XVR3EgxzOJj_Z86WKtgupvgahXBqse.AW2lAl4WSLfMOSxJ4EruG1hB8NN8HkqeOipunmUuhxMrOqo1TUz811jyyPRbcsU3CCAsmKwhVE7a0X4oBsClbE5awdQgk0LbN2CdhYNxJwCml.JI8KCGMGvE2bWkDjzGmYzpnPO3aWIrh.TLLlwAaTKNcHnRD.HkatLvAXfF7JgKkMxQEQSZNYa7y0h1qlB.HtEKt.4vSTKI0WheXBLgBYx.Gy5KtckybMN.V_QxioLWwI7eKGHBZpcYOIT7.vCt35EU6wUhrPhBjuNdZYTLvGKyQ1vhWlZEkuXLovVvd_8jeALqDPbHAZUbFxa5PY7s6fwk6amjKjJb.BrqvuH6kf0WnKDvp204BE_hkCFrtDbKQyW7hT7CePPdSspscHjwe4pCH45u1mgsz0cDT0Pa4ffP9EgqMxgttAPzr9RiNFiEFtsGF5tTSZHH.BQ08aXjLEVeJmbbrVmRw_34a1jMteuSUfo4b2_VDNJsJq7FArjOgl9WEdolSuuUluzVcqoH7LZozMHgKkmk9Gh8UvD85NE5DKGqpSZeczMscwaMbP3WHiK.PUCKjVCUOpOz9zTeivplh66So7ebPHbQLgnsO"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=9135213a4c52f8d0';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/abstracts\/149119\/immunoglobulin-g-glycosylation-profile-in-influenza-and-covid-19-infected-patients?__cf_chl_rt_tk=YsfVI.kEGQZdk85eboWiWnroBCQoUurVcOaMbMOxVGw-1739788517-1.0.1.1-L_vGNpDkZSk0KtkIhAjDXXWmejCctQNBJK4Vyanxx5s" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>